USANA Health Sciences

USANA Health Sciences, Inc. develops and manufactures nutritional, personal care and weight-management products. It operates under the following segments: USANA Nutritionals, USANA Foods, Personal Care and Skincare, and All Other. The firm's brands include Procosa and MagneCal D. The company was founded by Myron W. Wentz in September 1992 and is headquartered in Salt Lake City, UT.

Earnings data Q1 2021

Earnings data Q2 2021

Earnings data Q3 2021

Earnings data Q4 2021

Earnings data Q1 2022

Earnings data Q2 2022

Earnings data Q3 2022

Earnings data Q4 2022

Earnings data Q1 2023

Earnings data Q2 2023

Earnings data Q3 2023

Earnings data Q4 2023

Earnings data Q1 2024

Earnings data Q2 2024

Earnings data Q3 2024

Earnings data Q4 2024

USANA Health Sciences addresses challenges, eyes growth through cost management

USANA Health Sciences navigated a challenging operating environment by focusing on cost management, product demand trends, and growth strategies. Despite facing headwinds in China and Southeast Asia, the company remains resilient and poised for opportunities in new markets and acquisitions.

USANA Health Sciences reports solid Q1 results amid global challenges

USANA Health Sciences delivered strong Q1 results amidst global challenges, driven by robust demand for health products.
Strategic leadership transition and focus on cost management position the company for sustained growth and operational efficiency.
Opportunities in China market, new market launches, and enhanced customer engagement strategies offer avenues for future expansion.

USANA Health Sciences exceeds Q2 expectations, eyes India expansion

USANA Health Sciences delivered strong Q2 results with a focus on sustainable growth strategies and expansion into new markets. Challenges include tough year-over-year comparisons and cash flow impact from accrued liabilities.

USANA Health Sciences addresses challenges, eyes India expansion for growth

USANA Health Sciences navigated challenges in Q3 2023 with a focus on addressing operational hurdles and driving growth through strategic initiatives. The company's restructuring and expansion into India signal a commitment to long-term success and capitalizing on emerging opportunities.

USANA Health Sciences exceeds Q4 expectations, eyes global growth

USANA Health Sciences delivered strong performance in Q4 2023, driven by growth in Greater China and a solid financial position. While facing challenges such as currency fluctuations and market-specific issues, the company is well-positioned to capitalize on opportunities through strategic initiatives and market tailoring. By focusing on sustainable growth and innovation, USANA aims to further strengthen its market presence and drive profitability.

USANA Health Sciences reports mixed Q1 results, eyes growth strategies

USANA Health Sciences faced mixed results in Q1 2024, with Mainland China driving growth while other markets struggled. The company is addressing challenges through market-specific incentives and focusing on future strategies like product development and localization.

USANA Health Sciences adapts to market challenges with strategic focus

USANA Health Sciences navigated macroeconomic challenges by implementing strategic initiatives and restructuring its commercial team.
The company's focus on product innovation, market expansion into India, and leadership additions signal a commitment to sustainable success.
While facing challenges in market conditions, USANA aims to leverage opportunities like M&A activities and accelerated product development for growth.

USANA Health Sciences adapts strategies to drive growth amid challenges

USANA Health Sciences faced challenges in Q3 with lower-than-expected net sales, particularly in China, but is implementing strategies to boost performance.
The company's strengths in product innovation, streamlined development processes, and strong product lineup position it well for future growth.
Addressing challenges such as decreased average spend and revised guidance presents opportunities for USANA to enhance revenue and market presence.

Revenue

Cost of revenue

Gross profit

Operating expenses

SG&A

Other

Operating income

EBITDA

Net income

Earnings per share

Total assets

Current assets

Cash & equivalents

Receivables

Inventory

Non-current assets

Net PPE

Intangibles

Total liabilities

Current liabilities

Short term debt

Income tax payable

Non-current liabilities

Long-term debt

Total equity

Stockholders equity

Minority interest

Total liabilities & equity

Total debt

Net debt

Book value per share

Cash from operations

Funds from operations

Change in working capital

Cash from investing

Capital expenditure

Purchase/sale of investments

Purchase/sale of business

Other sources

Cash from financing

Change in stock

Change in debt

Cash dividends paid

Cash from other sources

Net change in cash

Free cash flow

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA), a leading developer and manufacturer of high-quality nutritional supplements, healthy foods and personal care products, today announced that it will host investor meetings and a fireside chat presentation at the ICR Conference in Orlando, FL on January 8-9, 2024. Doug Hekking, Chief Financial Officer, will be participating in the fireside chat, scheduled to begin at 10:30 AM ET on January 8, 2024. A live audio webcast of.

USANA Health Sciences to Participate in the 2024 ICR Conference

More than 4,300 bags of food distributed to local schools SALT LAKE CITY , Dec. 20, 2023 /PRNewswire/ -- The holiday season is a time of joy, but it can also be stressful for children who rely on in-school meals as their main food source. With schools going on holiday break, USANA Kids Eat has led a food pack to help keep families fed through the end of the year.

USANA Kids Eat Spreads Holiday Cheer with Meals for Utah Students and Families

Awarded by Utah Business Magazine for the Ninth Time SALT LAKE CITY , Dec. 14, 2023 /PRNewswire/ -- USANA Health Sciences, Inc., a leader in the health and wellness industry, was recently named a Best Company to Work For by Utah Business magazine. This marks the ninth time USANA has won this prestigious award.

USANA Named a Best Company to Work For in Utah

SALT LAKE CITY , Dec. 4, 2023 /PRNewswire/ -- Kevin Guest, executive chairman of USANA Health Sciences, is leading the charge this December, encouraging everyone to participate in National Giving Month. This initiative celebrates the generosity and volunteerism that unites people and builds relationships.

Kevin Guest Says Include Self-care in National Giving Month

Awarded for the second time by the Utah Manufacturers Association SALT LAKE CITY , Nov. 21, 2023 /PRNewswire/ -- USANA Health Sciences, Inc., a global leader in nutrition, was recently awarded Manufacturer of the Year by the Utah Manufacturers Association for its second consecutive year. To learn more about USANA, please visit USANA.com.

USANA Named Top Manufacturer in Utah

USANA Health Sciences, Inc. (NYSE:USNA ) Q3 2023 Earnings Conference Call October 25, 2023 11:00 AM ET Company Participants Andrew Masuda – Investor Relations Jim Brown – President and Chief Executive Officer Doug Hekking – Chief Financial Officer Brent Neidig – Chief Commercial Officer Conference Call Participants Anthony Lebiedzinski – Sidoti Doug Lane – Water Tower Research Ivan Feinseth – Tigress Financial Partners Operator Hello and welcome to USANA Health Sciences' Third Quarter Earnings Call. My name is Valeria and I'll be your coordinator for today's event.

USANA Health Sciences, Inc. (USNA) Q3 2023 Earnings Call Transcript

USANA Health Sciences (USNA) came out with quarterly earnings of $0.59 per share, missing the Zacks Consensus Estimate of $0.64 per share. This compares to earnings of $0.78 per share a year ago.

USANA Health Sciences (USNA) Q3 Earnings Miss Estimates

Usana Health Sciences Inc.'s stock USNA, +1.59% fell 2% before turning flat in after-hours trade Tuesday, after the maker of nutritional supplements missed earnings estimates for the third quarter. Salt Lake City, Utah-based Usana posted net income of $11.3 million, or 59 cents a share, for the quarter, down from $14.9 million, or 78 cents a share, in the year-earlier period.

Usana Health's stock dips then turns flat after earnings miss and lowered guidance

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal third quarter ended September 30, 2023. Key Financial & Operating Results Third quarter net sales were $213 million versus $233 million during Q3 2022. Third quarter diluted EPS was $0.59 as compared with $0.78 during Q3 2022. Company narrows fiscal year 2023 net sales and diluted EPS outlook to $900 million to $920 million and $2.80 to $3.05, respectively (previously $.

USANA Health Sciences Reports Third Quarter 2023 Results

USANA Health Sciences has a diversified international presence, with 90% of net sales coming from international markets. The company has a healthy balance sheet with strong liquidity and solid asset/liability ratio. The launch of new digital tools and affiliate programs in 2023 is expected to drive net sales growth in the coming years.

USANA: New Digital Tools And Solid Balance Sheet Imply Undervaluation

LAKE PLACID, N.Y. , Oct. 18, 2023 /PRNewswire/ -- USA Bobsled/Skeleton (USABS) announced this week that USANA Health Sciences will be signing as the new Official Supplement Supplier for the team.

USANA Joins the USA Bobsled/Skeleton Family as Official Supplement Supplier

USANA Health (USNA) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

Earnings Preview: USANA Health Sciences (USNA) Q3 Earnings Expected to Decline

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that third quarter results will be released after the close of market on Tuesday, October 24, 2023. Shortly following the issuance of the Company's earnings release, the Company will post its Management Commentary document on the Company's Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and instituti.

USANA Schedules Third Quarter Earnings Release and Conference Call

SALT LAKE CITY , Oct. 2, 2023 /PRNewswire/ -- With the pandemic largely in the rearview mirror, USANA Health Sciences Executive Chairman Kevin Guest is seeing huge workplace productivity benefits as employees transition back to the office. "True collaboration—the kind that sparks creativity, triggers innovation and thrives in an environment of face-to-face dialogue—is the lifeblood of any successful business," said Guest, who is author of the best-selling book, All the Right Reasons, 12 Timeless Principles for Living a Life in Harmony.

Kevin Guest Shares 5 Benefits of Returning to Office

SALT LAKE CITY , Sept. 6, 2023 /PRNewswire/ -- USANA Health Sciences, Inc., a leader in global nutrition, and its USANA Foundation are proud to participate in Hunger Action Month.

Join USANA for September #HungerActionMonth to Fight to End Hunger

SALT LAKE CITY , Aug. 31, 2023 /PRNewswire/ -- In recognition of September's Suicide Prevention Month and World Suicide Prevention Day on Sept. 10, Kevin Guest, Executive Chairman of USANA Health Sciences, is leveraging his platform to raise awareness about suicide prevention.

During Suicide Prevention Month, Make the Promise to Live, Urges USANA Executive Chairman Kevin Guest

Zoetis

Investors with an interest in Medical - Drugs stocks have likely encountered both USANA Health Sciences (USNA) and Zoetis (ZTS). But which of these two companies is the best option for those looking for undervalued stocks?

USNA vs. ZTS: Which Stock Should Value Investors Buy Now?

Suzanne Houghton honored by Utah Business  magazine SALT LAKE CITY , Aug. 16, 2023 /PRNewswire/ -- USANA Health Sciences, a leader in global nutrition, congratulates Talent Acquisition Manager Suzanne Houghton on her recent HR Achievement Award from Utah Business magazine. To learn more about USANA, please visit USANA.com.

USANA HR Professional Recognized for Excellence

SALT LAKE CITY , Aug. 14, 2023 /PRNewswire/ -- As a global leader in the health and wellness industry, USANA strives to continuously develop products featuring new, cutting-edge formulations. During its annual Americas & Europe Convention in Salt Lake City, USANA launched three new products.

USANA continues its industry-leading scientific innovation by announcing three new products at Americas & Europe Convention

SALT LAKE CITY , Aug. 1, 2023 /PRNewswire/ -- Throughout August, Kevin Guest, Executive Chairman at USANA Health Sciences (NYSE: USNA) and best-selling author of "All the Right Reasons - 12 Timeless Principles for Living a Life in Harmony," is encouraging individuals across the globe to celebrate happiness. With his message of focusing on life's positive aspects and appreciating the little things, Guest invites everyone to participate in August's "Happiness Happens Month" and make a profound impact on their own lives and the lives of those around them.

Kevin Guest Cites 5 Ways to Celebrate August's Happiness Month

USANA Health Sciences (USNA) came out with quarterly earnings of $0.89 per share, beating the Zacks Consensus Estimate of $0.70 per share. This compares to earnings of $1 per share a year ago.

USANA Health Sciences (USNA) Tops Q2 Earnings and Revenue Estimates

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE: USNA) today announced financial results for its fiscal second quarter ended July 1, 2023. Key Financial & Operating Results Second quarter net sales were $238 million versus $264 million during the second quarter of 2022. Second quarter diluted EPS was $0.89 as compared with $1.00 during the second quarter of 2022. Fiscal 2023 net sales and diluted EPS guidance updated to $900 to $950 million and $2.65 to $3.30, respectivel.

USANA Health Sciences Reports Second Quarter Net Sales of $238 Million and Diluted EPS of $0.89

USANA executive chairman to lead board focused on industry research SALT LAKE CITY , July 12, 2023 /PRNewswire/ -- USANA Executive Chairman Kevin Guest was recently named the new Chairman of the Direct Selling Education Foundation (DSEF). Over the next year, he'll help guide the strategic actions of the organization, which works with the academic community to support research in direct sales-related disciplines.

Kevin Guest Named Chairman of Direct Selling Education Foundation

SALT LAKE CITY--(BUSINESS WIRE)--USANA Health Sciences, Inc. (NYSE:USNA) today announced that second quarter results will be released after the close of market on Tuesday, July 25, 2023. Shortly following the issuance of the Company's earnings release, the Company will post its Management Commentary document on the Company's Investor Relations website (http://ir.usana.com) under the News/Events section. USANA will hold a conference call to discuss this announcement with analysts and institution.

USANA Schedules Second Quarter Earnings Release and Conference Call

SALT LAKE CITY , June 29, 2023 /PRNewswire/ -- In anticipation of International Self-Care Day on July 24, Kevin Guest, executive chairman of USANA Health Sciences (NYSE: USNA), a global leader in nutritional supplements, is urging individuals to prioritize their well-being and embrace self-care throughout July. Guest is emphasizing the importance of self-care as a fundamental aspect of overall health and happiness.

News for USANA Health Sciences Stock (USNA)